Inogen Announces Leadership Transition
Key Highlights
- ➤Andy Reding appointed President and CEO, succeeding Kevin Smith
- ➤Reding joined Inogen as COO in July 2026
- ➤Board cites need to improve performance and pursue sustainable, profitable growth
- ➤Inogen separately reports third-quarter 2026 financial results today
Expert Statements
Elizabeth Mora, Chairperson of Inogen’s Board of Directors
“With an expanded range of respiratory therapies and a growing international presence, Inogen has a significant opportunity to build on its strengths and drive sustainable, profitable growth.”
Elizabeth Mora, Chairperson of Inogen’s Board of Directors
“At the same time, we must do more to improve performance to capture the opportunity in front of us, and the Board has determined that now is the right time to make this transition.”
Elizabeth Mora, Chairperson of Inogen’s Board of Directors
“Andy brings proven experience in building high-performing teams and scaling complex medtech businesses like ours.”
Elizabeth Mora, Chairperson of Inogen’s Board of Directors
“He played a central role in the Rotech divestiture announced in September, which we expect will advance our shift toward a more streamlined commercial model.”
Elizabeth Mora, Chairperson of Inogen’s Board of Directors
“We believe his expertise in respiratory care and medical technology, together with his background leading commercial and operational organizations, makes him ideally positioned to lead Inogen through our next phase of growth.”
Andy Reding, President and Chief Executive Officer of Inogen
“I joined Inogen in July because I believe in the Company’s mission of improving the quality of life for people living with chronic respiratory conditions.”
Andy Reding, President and Chief Executive Officer of Inogen
“Over the last few months, my excitement about Inogen and our opportunities grew.”
Andy Reding, President and Chief Executive Officer of Inogen
“I came to better understand and appreciate the strength of our team, our differentiated product portfolio, and our deep customer relationships.”
Andy Reding, President and Chief Executive Officer of Inogen
“I also see significant opportunities for us to sharpen our focus, strengthen execution, and expand access to our innovative respiratory solutions, and I look forward to working with the team as we focus on creating value for customers and shareholders.”
Elizabeth Mora, Chairperson of Inogen’s Board of Directors
“On behalf of the Board, we are grateful for Kevin’s leadership and for the role he has played in helping broaden and expand Inogen’s reach.”
Chief Operating Officer Andy Reding Appointed President and Chief Executive Officer
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that its Board of Directors has appointed Andy Reding, the Company’s Chief Operating Officer, as President and Chief Executive Officer and a member of the Board of Directors. Mr. Reding succeeds Kevin Smith.
Get started
Create a free account to read the full story.